“Understanding the sex differences in obesity-related HFpEF is of great importance,” one cardiologist explained. “Obesity and visceral adiposity are key drivers of HFpEF development and progression, and this may be even more amplified in women."

Interventional cardiologist Peter Monteleone, MD, discussed the primary tools used to treat pulmonary embolism in the cath lab.

The new-look diet was linked to significant weight loss and reductions in HbA1C levels. Researchers see it as a potential alternative to immediately putting patients on new medications. 

A majority of U.S. surgeons, including those who treat heart patients on a daily basis, say their operating rooms use outdated technology. It is having a negative impact on patient care. 

“While the use of cannabis continues to gain popularity, its broader effects on public health within the general population are not yet fully understood,” one researcher said.

Vivek Reddy, MD, was involved in most of the late-breaking pulsed field ablation trials at Heart Rhythm 2024. He spoke to Cardiovascular Business at the conference about those trials and what they mean going forward.

It's clear that advanced AI algorithms will radically transform care for TAVR patients in the years ahead. For now, however, certain AI models may require too much data to be helpful on a consistent basis. 

Elutia, formerly known as Aziyo Biologics, is already targeting additional uses for the newly approved device.